Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Indaptus Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −3 vs. Q4 2022
- Shares held
- 579.3K
- +2.78K (+0.5%) vs. Q4 2022
- Total value
- $1.08M
- +$240.9K (+28.7%) vs. Q4 2022
- New holders
- 1
- 4 more added
- Sold out
- 4
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INDP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.15M |
| Q1 2026 | 6 | $128.5K |
| Q4 2025 | 4 | $93.7K |
| Q3 2025 | 5 | $57.9K |
| Q2 2025 | 5 | $3.23K |
| Q1 2025 | 19 | $377.8K |
| Q4 2024 | 20 | $539.6K |
| Q3 2024 | 18 | $750.2K |
| Q2 2024 | 21 | $1.26M |
| Q1 2024 | 17 | $1.31M |
| Q4 2023 | 19 | $1.06M |
| Q3 2023 | 16 | $1.57M |
| Q2 2023 | 15 | $1.11M |
| Q1 2023 | 15 | $1.08M |
| Q4 2022 | 18 | $838.5K |
| Q3 2022 | 18 | $1.22M |
| Q2 2022 | 17 | $1.31M |
| Q1 2022 | 17 | $6.81M |
| Q4 2021 | 15 | $10.5M |
| Q3 2021 | 15 | $4.24M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Indaptus Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 7 | $13 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19 | $35 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 99 | $183 | 0.00% | +1+1.0% | Added |
| Bangor Savings Bank | 400 | $740 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 829 | $1.53K | 0.00% | +300+56.7% | Added |
| Tower Research Capital LLC (TRC) | 6,140 | $11.0K | 0.00% | −602−8.9% | Reduced |
| Northern Trust Corp | 12,918 | $23.9K | 0.00% | +20+0.2% | Added |
| Renaissance Technologies LLC | 19,200 | $36.0K | 0.00% | +100+0.5% | Added |
| State Street Corp | 19,473 | $36.0K | 0.00% | 00.0% | Unchanged |
| Vivaldi Capital Management, LLC | 24,000 | $44.4K | 0.01% | 00.0% | Unchanged |
| Pine Valley Investments Ltd Liability Co | 44,420 | $89.7K | 0.01% | +44,420 | New |
| Geode Capital Management, LLC | 50,521 | $93.5K | 0.00% | 00.0% | Unchanged |
| Strategy Asset Managers LLC | 55,336 | $102.4K | 0.02% | 00.0% | Unchanged |
| Investment House LLC | 95,629 | $176.9K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 250,348 | $463.1K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −26,832−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,495−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −117−100.0% | Sold out |